The equity base has eroded by approximately 45% from $1.2B to $665.6M over ten quarters, with total debt rising to $475.9M and the debt-to-equity ratio increasing to 0.71, indicating a shift toward necessity-driven financing.
Evotec SE (EVO) balance sheet — 23-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 |
|---|
| Total Current Assets | 663.26M | 762.62M | 681.96M | 903.16M | 1.07B | 1.1B | 806.13M | 527.05M | 249.77M | 180.25M | 169.24M | 166.94M | 125.3M | 122.53M | 88.1M | 83.33M | 86.69M | 68.96M | 93.08M | 111.84M | 113.82M | 81.97M | 65.5M | 34.74M |
| Cash & Short-Term Investments | 418.48M | 476.19M | 396.8M | 604.11M | 707.31M | 858.5M | 589.67M | 359.22M | 149.88M | 101.58M | 127.86M | 134.96M | 89.92M | 98.14M | 65.64M | 63.78M | 68.54M | 58.36M | 84.1M | 96.13M | 78.72M | 53.52M | 64.15M | 32.9M |
| Cash Only | 299.01M | 418.34M | 306.39M | 510.91M | 400.7M | 699.33M | 517.05M | 310.97M | 109.06M | 67.02M | 83.94M | 44.5M | 48.71M | 45.64M | 39.06M | 17.78M | 21.09M | 32.93M | 55.06M | 37.99M | 78.72M | 53.52M | 4.12M | 1.39M |
| Short-Term Investments | 119.47M | 57.85M | 90.41M | 93.2M | 306.61M | 159.17M | 72.62M | 48.25M | 40.82M | 34.56M | 43.92M | 90.46M | 41.21M | 52.49M | 26.57M | 46.01M | 47.45M | 25.43M | 29.03M | 58.14M | 0 | 0 | 60.03M | 31.51M |
| Accounts Receivable | 171.27M | 213.42M | 218.38M | 221.9M | 275.77M | 176.75M | 167.48M | 139.34M | 60.94M | 69.98M | 29.83M | 22.19M | 26.15M | 18.21M | 15.53M | 10.59M | 12.44M | 4.86M | 3.9M | 9.17M | 7.77M | 14.13M | 16.34M | 0 |
| Days Sales Outstanding | 86.27 | 102.87 | 100.02 | 103.65 | 133.95 | 104.39 | 122.03 | 113.92 | 59.25 | 99.14 | 66.18 | 63.44 | 106.63 | 77.34 | 64.97 | 48.26 | 82.15 | 41.53 | 35.97 | 101.75 | 42.11 | 80.43 | 3.08K | - |
| Inventory | 37.71M | 29.3M | 31.12M | 30.89M | 29.82M | 25.79M | 16.62M | 12.07M | 5.66M | 9.02M | 4.3M | 3.13M | 3.11M | 2.36M | 2.44M | 3.56M | 2.82M | 2.42M | 2.14M | 2.39M | 4.78M | 10.5M | 0 | 0 |
| Days Inventory Outstanding | 20.18 | 15.4 | 16.65 | 18.59 | 18.85 | 20.18 | 16.17 | 14.05 | 7.84 | 18.8 | 14.83 | 12.75 | 18.89 | 15.73 | 15.87 | 28.75 | 33.28 | 36.48 | 35.53 | 35.15 | 39.31 | 89.17 | - | - |
| Other Current Assets | 35.8M | 24.75M | 13.42M | 27.87M | 43.82M | 20.68M | 21.04M | 6.13M | 25.27M | 17.03M | 2.68M | 3.39M | 2.51M | 2.11M | 1.16M | 721K | 0 | 1.43M | 951K | 0 | 27.89M | 0 | 3.15M | 0 |
| Total Non-Current Assets | 841.71M | 1.02B | 1.23B | 1.35B | 1.18B | 1.13B | 1.03B | 852.81M | 522.11M | 487.02M | 182.13M | 121.6M | 99.3M | 104.85M | 137.32M | 134.88M | 105.17M | 77.64M | 89.82M | 96.04M | 91.71M | 104.14M | 5.41M | 6.99M |
| Property, Plant & Equipment | 444.54M | 554.39M | 823.94M | 806.56M | 650.2M | 484.6M | 412.7M | 268.53M | 90.52M | 74.66M | 43.42M | 38.33M | 24.05M | 24.24M | 27.18M | 24.95M | 18.49M | 19.16M | 18.47M | 18.46M | 34.67M | 38.16M | 4.44M | 4.46M |
| Fixed Asset Turnover | 1.46x | 1.37x | 0.97x | 0.97x | 1.16x | 1.28x | 1.21x | 1.66x | 4.15x | 3.45x | 3.79x | 3.33x | 3.72x | 3.55x | 3.21x | 3.21x | 2.99x | 2.23x | 2.14x | 1.78x | 1.94x | 1.68x | 0.44x | 0.80x |
| Goodwill | 0 | 272.25M | 282.85M | 275.63M | 274.82M | 257.57M | 302.67M | 287.27M | 220.79M | 220.18M | 93.23M | 45.65M | 44.81M | 40.14M | 42.34M | 42.2M | 25.98M | 16.56M | 13.29M | 39.04M | 48.91M | 0 | 0 | 0 |
| Intangible Assets | 0 | 31.56M | 26.44M | 15.45M | 23.82M | 30.85M | 119.95M | 131.33M | 122.99M | 135.03M | 22.45M | 25.15M | 30.21M | 39.83M | 63.27M | 67.65M | 57.62M | 29.01M | 47.17M | 37.48M | 42.99M | 14.13M | 16.34M | 0 |
| Long-Term Investments | 187.74M | 52.61M | 42.15M | 142.09M | 150.33M | 287.01M | 72.22M | 46.31M | 28.99M | 22.14M | 3.97M | 80K | 91K | 87K | 85K | -45.93M | 3.09M | 10K | 427K | -57.06M | -20.47M | -93.44M | 0 | 0 |
| Other Non-Current Assets | 50.61M | 36.84M | 37.82M | 95.23M | 74.08M | 56.84M | 45.73M | 26.56M | 15.5M | 15.77M | 8.47M | 3.57M | 139K | 566K | 1.63M | 46.01M | 3.09M | 12.9M | 10.47M | 58.12M | 1.98M | 159.42M | 192.53K | 779.74K |
| Total Assets | 1.5B | 1.78B | 1.91B | 2.25B | 2.26B | 2.24B | 1.84B | 1.38B | 771.88M | 667.27M | 351.37M | 288.54M | 224.6M | 227.38M | 225.43M | 218.21M | 191.86M | 146.6M | 182.9M | 207.88M | 205.53M | 186.11M | 70.91M | 41.73M |
| Asset Turnover | 0.44x | 0.43x | 0.42x | 0.35x | 0.33x | 0.28x | 0.27x | 0.32x | 0.49x | 0.39x | 0.47x | 0.44x | 0.40x | 0.38x | 0.39x | 0.37x | 0.29x | 0.29x | 0.22x | 0.16x | 0.33x | 0.34x | 0.03x | 0.09x |
| Asset Growth % | -69.85% | -7.03% | -15.09% | -0.21% | 0.99% | 21.63% | 33.18% | 78.76% | 15.68% | 89.91% | 21.77% | 28.47% | -1.22% | 0.87% | 3.31% | 13.74% | 30.87% | -19.85% | -12.02% | 1.14% | 10.43% | 162.46% | 69.94% | - |
| Total Current Liabilities | 285.64M | 367.92M | 344.58M | 464.57M | 337.71M | 324.52M | 255.06M | 200.88M | 196.28M | 245.78M | 73.39M | 56.4M | 33.07M | 38.95M | 33.88M | 42.83M | 32.8M | 26.45M | 21.83M | 24.34M | 55.48M | 29.67M | 7.61M | 5.15M |
| Accounts Payable | 48.58M | 64.74M | 85.79M | 134.32M | 97.28M | 72.6M | 52.06M | 35.16M | 31.14M | 26.08M | 12M | 12.17M | 9.45M | 6.65M | 6.36M | 10.13M | 6.98M | 5.24M | 7.19M | 15.09M | 11.48M | 8.11M | 1.25M | 543.91K |
| Days Payables Outstanding | 31.66 | 34.02 | 45.91 | 80.85 | 61.49 | 56.8 | 50.65 | 40.92 | 43.15 | 54.37 | 41.33 | 49.53 | 57.37 | 44.38 | 41.29 | 81.94 | 82.41 | 78.76 | 119.43 | 221.58 | 94.37 | 68.87 | - | - |
| Short-Term Debt | 0 | 103.64M | 50.8M | 149.1M | 1.56M | 36.14M | 36.72M | 23.27M | 55.07M | 167.76M | 21.41M | 14.21M | 13.36M | 17.22M | 13.22M | 13.17M | 8.58M | 10.27M | 2.58M | 1.3M | 2.59M | 6.04M | 1.05M | 1.25M |
| Deferred Revenue (Current) | 286.91M | 108.02M | 109.81M | 107.86M | 136.67M | 126.78M | 86.44M | 82.4M | 61.19M | 18.99M | 15.91M | 8.86M | 3.35M | 6.28M | 5.78M | 18.19M | 7.67M | 5.48M | 1.24M | 6.58M | 12.68M | 7.5M | 3.37M | 0 |
| Other Current Liabilities | 164.27M | 41.18M | 84.21M | 45.83M | 76.54M | 63.93M | 31.68M | 17.17M | 16.74M | 29.44M | 10.23M | 6.91M | 6.91M | 6.67M | 5.36M | 13.13M | 7.26M | 4.99M | 8.74M | 7.06M | 40.21M | 11.67M | 5.28M | 3.03M |
| Current Ratio | 2.32x | 2.07x | 1.98x | 1.94x | 3.18x | 3.39x | 3.16x | 2.62x | 1.27x | 0.73x | 2.31x | 2.96x | 3.79x | 3.15x | 2.60x | 1.95x | 2.64x | 2.61x | 4.26x | 4.60x | 2.05x | 2.76x | 8.61x | 6.74x |
| Quick Ratio | 2.19x | 1.99x | 1.89x | 1.88x | 3.09x | 3.31x | 3.10x | 2.56x | 1.24x | 0.70x | 2.25x | 2.90x | 3.70x | 3.08x | 2.53x | 1.86x | 2.56x | 2.52x | 4.17x | 4.50x | 1.97x | 2.41x | 8.61x | 6.74x |
| Cash Conversion Cycle | 74.79 | 84.25 | 70.76 | 41.39 | 91.31 | 67.77 | 87.56 | 87.04 | 23.95 | 63.57 | 39.68 | 26.66 | 68.15 | 48.69 | 39.54 | -4.93 | 33.03 | -0.74 | -47.93 | -84.69 | -12.95 | 100.74 | - | - |
| Total Non-Current Liabilities | 577.67M | 596.72M | 615.39M | 667.99M | 732.36M | 532.96M | 696.2M | 643.51M | 150.73M | 89.75M | 64.04M | 45.04M | 33.15M | 29.46M | 39M | 28.14M | 26.42M | 8.67M | 11.21M | 12.99M | 12.88M | 7.77M | 1.58M | 543.12K |
| Long-Term Debt | 417.21M | 194.82M | 392.74M | 477.11M | 328.3M | 326.34M | 405.02M | 364.68M | 54.68M | 20.3M | 7.19M | 8.73M | 8.19M | 0 | 4.18M | 2.36M | 3.5M | 3.76M | 8.05M | 9.13M | 6.3M | 3.4M | 1.58M | 543.12K |
| Capital Lease Obligations | 307.14M | 149.04M | 0 | 170.03M | 162M | 135.96M | 160.21M | 131.87M | 2.87M | 1.17M | 30K | 0 | 0 | 14K | 0 | 1K | 32K | 132K | 346K | 700K | 1.83M | 2.13M | 0 | 0 |
| Deferred Tax Liabilities | 104.18M | 79.51M | 14.52M | 18.14M | 18.52M | 17.69M | 73.39M | 78.08M | 21.52M | 23.5M | 115K | 1.54M | 1.58M | 1.25M | 2.1M | 9.9M | 6.66M | 1.98M | 1.46M | 1.6M | 6.45M | 0 | 0 | 0 |
| Other Non-Current Liabilities | 27.38M | 19.74M | 20.9M | -152.57M | 17.4M | 18.49M | 25.62M | 25.3M | 20.62M | 16.11M | 15.57M | 28.27M | 19.04M | 19.82M | 20.2M | 15.86M | 12.72M | 832K | 779K | 1.02M | -2.82M | 1.51M | 0 | 0 |
| Total Liabilities | 863.31M | 964.64M | 959.98M | 1.13B | 1.07B | 857.48M | 951.26M | 844.39M | 347M | 335.52M | 137.43M | 101.44M | 66.22M | 68.41M | 72.88M | 70.97M | 59.22M | 35.11M | 33.04M | 37.33M | 68.35M | 37.44M | 9.18M | 5.7M |
| Total Debt | 417.21M | 447.5M | 443.54M | 815.35M | 506.67M | 512.92M | 601.94M | 519.83M | 114.47M | 189.93M | 28.83M | 22.94M | 21.55M | 17.24M | 17.4M | 16.71M | 12.22M | 14.38M | 11.33M | 11.66M | 11.91M | 13.27M | 2.62M | 1.8M |
| Net Debt | 118.19M | 29.16M | 137.15M | 304.44M | 105.98M | -186.41M | 84.9M | 208.86M | 5.41M | 122.91M | -55.11M | -21.55M | -27.16M | -28.4M | -21.66M | -1.06M | -8.87M | -18.54M | -43.74M | -26.33M | -66.82M | -40.25M | -1.49M | 404.16K |
| Debt / Equity | 0.65x | 0.55x | 0.47x | 0.73x | 0.43x | 0.37x | 0.68x | 0.97x | 0.27x | 0.57x | 0.13x | 0.12x | 0.14x | 0.11x | 0.11x | 0.11x | 0.09x | 0.13x | 0.08x | 0.07x | 0.09x | 0.09x | 0.04x | - |
| Debt / EBITDA | -14.15x | - | - | 17.93x | 4.87x | 4.60x | 5.75x | 4.67x | 1.05x | 3.26x | 0.67x | 0.97x | 10.00x | - | 3.10x | 1.41x | 1.69x | - | - | - | - | - | - | - |
| Net Debt / EBITDA | -4.01x | - | - | 6.70x | 1.02x | -1.67x | 0.81x | 1.87x | 0.05x | 2.11x | -1.27x | -0.91x | -12.60x | - | -3.86x | -0.09x | -1.23x | - | - | - | - | - | - | - |
| Interest Coverage | -11.96x | -7.89x | -15.58x | -5.87x | -10.71x | 26.61x | 4.05x | 5.09x | 28.79x | 21.27x | 22.63x | 8.24x | -2.91x | -12.42x | -2.32x | 3.83x | 5.47x | -102.51x | -89.55x | -30.69x | -49.32x | -49.91x | - | - |
| Total Equity | 641.66M | 813.36M | 952.52M | 1.12B | 1.19B | 1.38B | 886.41M | 535.47M | 424.88M | 331.75M | 213.94M | 187.09M | 158.38M | 158.97M | 152.55M | 147.25M | 132.64M | 111.49M | 149.86M | 170.55M | 137.18M | 148.67M | 61.06M | -62.37M |
| Equity Growth % | -96.3% | -14.61% | -14.95% | -5.67% | -13.83% | 55.42% | 65.54% | 26.03% | 28.07% | 55.07% | 14.35% | 18.13% | -0.37% | 4.21% | 3.6% | 11.01% | 18.97% | -25.61% | -12.13% | 24.33% | -7.73% | 143.47% | 197.9% | - |
| Book Value per Share | 1.80 | 2.29 | 2.69 | 3.16 | 3.36 | 4.14 | 2.88 | 1.79 | 1.44 | 1.14 | 0.81 | 0.68 | 0.60 | 0.66 | 0.65 | 0.63 | 0.61 | 0.52 | 0.79 | 1.19 | 2.34 | 2.76 | 1.41 | -34.72 |
| Total Shareholders' Equity | 641.66M | 813.36M | 952.52M | 1.12B | 1.19B | 1.38B | 886.41M | 535.47M | 424M | 330.75M | 213.03M | 185.5M | 158.38M | 158.97M | 152.55M | 147.25M | 132.16M | 110.87M | 149.86M | 170.55M | 137.18M | 148.67M | 61.06M | -62.37M |
| Common Stock | 177.91M | 177.7M | 177.55M | 177.19M | 176.95M | 176.61M | 200.56M | 169.39M | 149.06M | 147.53M | 133.05M | 132.58M | 131.71M | 131.46M | 118.55M | 118.32M | 115.6M | 108.84M | 108.84M | 73.87M | 68.08M | 62.76M | 17.7K | 794 |
| Retained Earnings | -971.22M | -775.56M | -672.37M | -476.29M | -392.38M | -216.42M | -529.36M | -495.22M | -481.01M | -566.73M | -592.93M | -622.31M | -638.83M | -631.85M | -606.42M | -608.89M | -615.64M | -618.9M | -573.38M | -495.09M | -506.88M | -474.41M | -89.98M | -65.14M |
| Treasury Stock | -531K | -1.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1K | 0 | 0 | 0 | -99K | -83K | 0 | 0 | 0 |
| Accumulated OCI | -35.18M | -45.09M | -7.35M | -30.64M | -37.4M | -12.64M | -45.91M | -21.96M | -27.2M | -28.9M | -25.15M | -18.51M | -23.17M | -27.41M | -25.5M | -35.07M | -26.68M | -27.48M | -26.84M | -27.48M | -65.31M | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 876K | 992K | 901K | 1.59M | 0 | 0 | 0 | 0 | 476K | 613K | 0 | 0 | -6K | 0 | 0 | 0 |
Quick answers to the most common questions about buying EVO stock.
As of 2025, Evotec SE (EVO) had total assets of $1.78B including $762.6M in current assets.
Evotec SE (EVO) carries total debt of $447.5M, offset by $476.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Evotec SE (EVO) has total shareholders' equity (book value) of $813.4M ($2.29 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Evotec SE (EVO) reported a current ratio of 2.07x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Eroding equity base from persistent losses
Equity Erosion Accelerates
Evotec's total equity has contracted by approximately 45% from $1.2B in Q1 2024 to $665.6M in Q2 2026, driven by a deepening deficit in retained earnings that now stands at -$944.5M, signaling a significant and ongoing destruction of shareholder value.
The balance sheet trajectory is clearly weakening, with the equity base shrinking in every recent quarter. This erosion is not driven by share buybacks but by the accumulation of net losses, as evidenced by the retained earnings deficit growing from -$536.7M to -$944.5M over the period. This trend suggests the company's operational model is currently consuming capital rather than generating it, placing the long-term sustainability of the balance sheet in question without a clear path to profitability.
Cash Buffer Volatile but Adequate
Despite a volatile cash position that dipped to $174.0M in Q3 2025, Evotec's current ratio of 2.33 in Q2 2026 indicates a strong short-term liquidity buffer, though the recent increase in total debt to $475.9M warrants monitoring.
The company maintains a healthy current ratio, suggesting it can cover near-term obligations. However, the cash balance has been erratic, swinging from $462.6M to $174.0M and back to $348.4M, which may reflect lumpy project payments or working capital inefficiencies rather than stable operational cash generation. The recent rise in total debt to its highest level in the dataset, concurrent with a cash burn, suggests that liquidity is being maintained partly through increased borrowing, a dynamic that cannot persist indefinitely.
Leverage Creeps Higher on Cash Burn
Total debt has increased to $475.9M in Q2 2026 from $387.9M in Q1, pushing the debt-to-equity ratio to 0.71, a notable rise from the 0.55 level maintained for several quarters, indicating a shift toward necessity-driven financing.
The D/E ratio has moved from a conservative 0.55 to 0.71 in a single quarter, driven by both a rise in debt and a decline in equity. This change appears to be a direct consequence of the company's negative free cash flow and operating losses, forcing it to rely more on external financing. While the absolute leverage level is not yet critical, the direction of travel is concerning and suggests that the balance sheet is becoming more constrained as the path to profitability remains unclear.
Asset Base Contracts with Capacity
Total assets have declined from $2.4B to $1.6B over the past ten quarters, with a sharp reduction in PPE from $918.8M to $449.8M, suggesting significant asset dispositions or write-downs that may reflect underutilized capacity.
The substantial decline in net PPE, which has been cut nearly in half, is a major driver of the shrinking asset base. This could indicate the sale of facilities, accelerated depreciation, or impairment charges related to the J.POD manufacturing platform or other infrastructure. Combined with a reduction in goodwill, the asset profile is becoming leaner, but this contraction appears to be a defensive reaction to lower revenue and utilization rather than a strategic optimization, raising questions about the future scalability of the platform.
Deferred Revenue Collapse Signals Pipeline Risk
The complete disappearance of deferred revenue from $254.7M in Q1 2026 to $0 in Q2 2026 is a critical red flag, suggesting a potential loss of prepaid contracts or a fundamental shift in the company's ability to secure advance payments for its services.
Deferred revenue is a key forward indicator for a project-based business like Evotec, representing cash collected for services not yet delivered. Its abrupt elimination to zero is highly unusual and warrants immediate investigation. This could imply the termination of a major partnership, a change in contract terms, or a failure to renew prepaid agreements. Given the company's reliance on long-term partnerships, this metric's collapse may signal a more severe deterioration in business visibility and future revenue streams than the headline numbers suggest.